CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p149

Related search